These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 18059317

  • 1. Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.
    Rahman S, Zhang Z, Papke RL, Crooks PA, Dwoskin LP, Bardo MT.
    Br J Pharmacol; 2008 Feb; 153(4):792-804. PubMed ID: 18059317
    [Abstract] [Full Text] [Related]

  • 2. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.
    Rahman S, Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT.
    Neuropharmacology; 2007 Mar; 52(3):755-63. PubMed ID: 17097117
    [Abstract] [Full Text] [Related]

  • 3. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
    Smith AM, Dhawan GK, Zhang Z, Siripurapu KB, Crooks PA, Dwoskin LP.
    Biochem Pharmacol; 2009 Oct 01; 78(7):889-97. PubMed ID: 19631612
    [Abstract] [Full Text] [Related]

  • 4. The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.
    Rahman S, Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):103-5. PubMed ID: 19000671
    [Abstract] [Full Text] [Related]

  • 5. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
    Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT.
    Psychopharmacology (Berl); 2006 Mar 28; 184(3-4):426-34. PubMed ID: 16220336
    [Abstract] [Full Text] [Related]

  • 6. N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
    Dwoskin LP, Wooters TE, Sumithran SP, Siripurapu KB, Joyce BM, Lockman PR, Manda VK, Ayers JT, Zhang Z, Deaciuc AG, McIntosh JM, Crooks PA, Bardo MT.
    J Pharmacol Exp Ther; 2008 Aug 28; 326(2):563-76. PubMed ID: 18460644
    [Abstract] [Full Text] [Related]

  • 7. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
    Wooters TE, Smith AM, Pivavarchyk M, Siripurapu KB, McIntosh JM, Zhang Z, Crooks PA, Bardo MT, Dwoskin LP.
    Br J Pharmacol; 2011 May 28; 163(2):346-57. PubMed ID: 21232049
    [Abstract] [Full Text] [Related]

  • 8. Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.
    Smith AM, Pivavarchyk M, Wooters TE, Zhang Z, Zheng G, McIntosh JM, Crooks PA, Bardo MT, Dwoskin LP.
    Biochem Pharmacol; 2010 Aug 01; 80(3):402-9. PubMed ID: 20346923
    [Abstract] [Full Text] [Related]

  • 9. Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors.
    Ericson M, Molander A, Löf E, Engel JA, Söderpalm B.
    Eur J Pharmacol; 2003 Apr 25; 467(1-3):85-93. PubMed ID: 12706460
    [Abstract] [Full Text] [Related]

  • 10. Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.
    Natividad LA, Tejeda HA, Torres OV, O'Dell LE.
    Synapse; 2010 Feb 25; 64(2):136-45. PubMed ID: 19771590
    [Abstract] [Full Text] [Related]

  • 11. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.
    Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, Zanardi A, Rimondini R, Mugnaini M, Clementi F, Chiamulera C, Zoli M.
    J Neurosci; 2010 Apr 14; 30(15):5311-25. PubMed ID: 20392953
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice.
    Zanetti L, Picciotto MR, Zoli M.
    Psychopharmacology (Berl); 2007 Feb 14; 190(2):189-99. PubMed ID: 17061109
    [Abstract] [Full Text] [Related]

  • 13. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo.
    Fu Y, Matta SG, Gao W, Sharp BM.
    Neuroscience; 2000 Feb 14; 101(2):369-75. PubMed ID: 11074160
    [Abstract] [Full Text] [Related]

  • 14. Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).
    Dwoskin LP, Joyce BM, Zheng G, Neugebauer NM, Manda VK, Lockman P, Papke RL, Bardo MT, Crooks PA.
    Biochem Pharmacol; 2007 Oct 15; 74(8):1271-82. PubMed ID: 17727820
    [Abstract] [Full Text] [Related]

  • 15. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release.
    Nisell M, Nomikos GG, Svensson TH.
    Pharmacol Toxicol; 1994 Dec 15; 75(6):348-52. PubMed ID: 7534921
    [Abstract] [Full Text] [Related]

  • 16. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.
    Nisell M, Nomikos GG, Svensson TH.
    Synapse; 1994 Jan 15; 16(1):36-44. PubMed ID: 8134899
    [Abstract] [Full Text] [Related]

  • 17. Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine.
    Blomqvist O, Ericson M, Engel JA, Söderpalm B.
    Eur J Pharmacol; 1997 Sep 10; 334(2-3):149-56. PubMed ID: 9369343
    [Abstract] [Full Text] [Related]

  • 18. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.
    Fu Y, Matta SG, Gao W, Brower VG, Sharp BM.
    J Pharmacol Exp Ther; 2000 Aug 10; 294(2):458-65. PubMed ID: 10900219
    [Abstract] [Full Text] [Related]

  • 19. Nicotine enhances responding for conditioned reinforcement via α4β2 nicotinic acetylcholine receptors in the ventral tegmental area, but not the nucleus accumbens or the prefrontal cortex.
    Tabbara RI, Fletcher PJ.
    Neuropharmacology; 2019 Apr 10; 148():68-76. PubMed ID: 30550794
    [Abstract] [Full Text] [Related]

  • 20. Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues.
    Löf E, Olausson P, deBejczy A, Stomberg R, McIntosh JM, Taylor JR, Söderpalm B.
    Psychopharmacology (Berl); 2007 Dec 10; 195(3):333-43. PubMed ID: 17703283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.